Department of Musculoskeletal Cancer, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine Central South University, Changsha, PR, China.
Department of Orthopaedics, Hunan Aerospace Hospital, Changsha, China.
Bioengineered. 2021 Dec;12(1):1576-1586. doi: 10.1080/21655979.2021.1920326.
Osteosarcoma (OS) is an aggressive malignant tumor with a high rate of lung metastasis and a lack of therapeutic targets. Although the anomalous expression of long non-coding RNA (lncRNA) has been extensively documented in human cancer, its contribution to OS metastasis remains poorly understood. In this study, we found that MIR205 host gene (MIR205HG) was significantly elevated in human OS tissues, especially in metastatic OS tissues. Stable knockdown of MIR205HG inhibited OS cell invasion and lung metastatic foci formation, but did not affect cell viability. The vast majority of MIR205HG was situated in the cytosol, and served as a competing endogenous RNA (ceRNA) that directly bound to microRNA 2114-3p (miR-2114-3p), resulting in increased twist family bHLH transcription factor 2 (TWIST2) level. Pre-clinically, high MIR205HG was linked with dismal overall and relapse-free survival. Functionally, the attenuated cell invasion caused by MIR205HG knockdown was effectively rescued by miR-2114-3p silencing or TWIST2 overexpression. Overall, our findings suggest that the previously uncharacterized regulatory axis of MIR205HG/miR-2114-3p/TWIST2 plays a critical role in promoting OS metastasis, which implies a potential therapeutic target in OS patients with metastasis.
骨肉瘤(OS)是一种具有高肺转移率和缺乏治疗靶点的侵袭性恶性肿瘤。尽管长链非编码 RNA(lncRNA)的异常表达在人类癌症中已有广泛报道,但它对 OS 转移的贡献仍知之甚少。在这项研究中,我们发现 MIR205 宿主基因(MIR205HG)在人类 OS 组织中显著升高,尤其是在转移性 OS 组织中。MIR205HG 的稳定敲低抑制了 OS 细胞的侵袭和肺转移灶的形成,但不影响细胞活力。绝大多数 MIR205HG 位于细胞质中,作为一种竞争性内源性 RNA(ceRNA),直接与 microRNA 2114-3p(miR-2114-3p)结合,导致 TWIST 家族 bHLH 转录因子 2(TWIST2)水平升高。在临床前研究中,高 MIR205HG 与总体生存率和无复发生存率降低有关。在功能上,MIR205HG 敲低引起的细胞侵袭减弱可被 miR-2114-3p 沉默或 TWIST2 过表达有效挽救。总之,我们的研究结果表明,MIR205HG/miR-2114-3p/TWIST2 的这一先前未被描述的调控轴在促进 OS 转移中起着关键作用,这意味着在转移性 OS 患者中可能存在一种潜在的治疗靶点。